The Valley Desk

Clinical trial reportEuropean journal of cancer (Oxford, England : 1990)Published

Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
European journal of cancer (Oxford, England : 1990)
Published
Subject terms
Humans; Gastrointestinal Stromal Tumors; Constipation; Urea; Naphthyridines; Quality of Life; Imatinib Mesylate; Patient Reported Outcome Measures; Sunitinib; Quality of life; Gastrointestinal Stromal Tumours; Protein Kinase Inhibitors
PubMed ID
37598656
Added to directory
Source checked

Report a correction or request removal